Clik here to view.
TXMD All Set For D-day, IMMU Soars On Strategic Plan, CTSO On Watch
TXMD All Set For D-day, IMMU Soars On Strategic Plan, CTSO On Watch
View ArticleClik here to view.
Clik here to view.
Bristol-Myers & Seattle Genetics To Evaluate Combination Of Opdivo And ADCETRIS
Bristol-Myers & Seattle Genetics To Evaluate Combination Of Opdivo And ADCETRIS
View ArticleClik here to view.
Clik here to view.
Gainers & Losers Of June 12: GTXI, XBIT, NDRM, CHRS, ZYNE...
Gainers & Losers Of June 12: GTXI, XBIT, NDRM, CHRS, ZYNE...
View ArticleClik here to view.
Seattle Genetics Discontinues Phase 3 CASCADE Trial In Frontline AML
Seattle Genetics Discontinues Phase 3 CASCADE Trial In Frontline AML
View ArticleClik here to view.
Stocks May Benefit From Strength Overseas - U.S. Commentary
Stocks May Benefit From Strength Overseas - U.S. Commentary
View ArticleClik here to view.
Seattle Genetics Climbs Well Off Worst Levels But Remains Firmly Negative
Seattle Genetics Climbs Well Off Worst Levels But Remains Firmly Negative
View ArticleClik here to view.
AMGN's Xgeva To Face FDA In Feb, Double Treat For LPCN, SGEN Drops Cascade
AMGN's Xgeva To Face FDA In Feb, Double Treat For LPCN, SGEN Drops Cascade
View ArticleClik here to view.
Takeda, Seattle Genetics Report Positive Results From Phase 3 ECHELON-1 Trial
Takeda, Seattle Genetics Report Positive Results From Phase 3 ECHELON-1 Trial
View ArticleClik here to view.
Gainers & Losers Of June 26: AVEO, MBRX, SELB, NEOT, SGEN...
Gainers & Losers Of June 26: AVEO, MBRX, SELB, NEOT, SGEN...
View ArticleClik here to view.
Seattle Genetics Gets Canadian Marketing Authorization For Adcetris
Seattle Genetics Gets Canadian Marketing Authorization For Adcetris
View ArticleClik here to view.
ABIO To Report Data In Q1; IOVA Fired Up, PMD In Iowa, VRX All Cleared
ABIO To Report Data In Q1; IOVA Fired Up, PMD In Iowa, VRX All Cleared
View ArticleClik here to view.
Unum Therapeutics: IND Application Active For ACTR087 With SEA-BCMA
Unum Therapeutics: IND Application Active For ACTR087 With SEA-BCMA
View ArticleClik here to view.
Genmab: Seattle Genetics Exercises Option To Co-develop Tisotumab Vedotin
Genmab: Seattle Genetics Exercises Option To Co-develop Tisotumab Vedotin
View ArticleClik here to view.
Seattle Genetics To Present At Morgan Stanley Conference; Webcast At 2:05 PM ET
Seattle Genetics To Present At Morgan Stanley Conference; Webcast At 2:05 PM ET
View ArticleClik here to view.
Seattle Genetics' ADCETRIS Gets FDA Breakthrough Therapy Designation
Seattle Genetics' ADCETRIS Gets FDA Breakthrough Therapy Designation
View ArticleClik here to view.
CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4
CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4
View ArticleClik here to view.
AERI Faces D-Day, PTI To Report Data In Q4, MACK Makes Peace, MNKD Pulls Back
AERI Faces D-Day, PTI To Report Data In Q4, MACK Makes Peace, MNKD Pulls Back
View ArticleClik here to view.
Seattle Genetics Submits SBLA To FDA For ADCETRIS In Frontline Hodgkin Lymphoma
Seattle Genetics Submits SBLA To FDA For ADCETRIS In Frontline Hodgkin Lymphoma
View Article